Abnormal natural killer cell activity in systemic lupus erythematosus

An intrinsic defect in the lytic event

P. Katz, A. M. Zaytoun, J. H. Lee, R. S. Panush, S. Longley

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The natural killer (NK) cell activity in fifteen systemic lupus erythematosus (SLE) patients was investigated by employing 51-chromium (51Cr) release microcytotoxicity and single cell cytotoxicity assays against K562 target cells. Although the SLE patients as a group had depressed NK function in the 51Cr-release assay compared to normal subjects (p < 0.005), those with clinically active disease displayed the greatest impairment in this activity (p < 0.001). Active SLE patients were deficient in overall NK activity (Vmax) (p < 0.005) but had normal percentages of potentially cytotoxic target binding cells (TBC). These TBC, however, were unable to normally kill bound target cells (p < 0.01), which is indicative of a deficiency of 'active' NK cells (p < 0.005). Those NK cells with intact cytotoxic capabilities could 'recycle' and repeat the lytic sequence normally. Exposure of normal lymphocytes to SLE sera did not impair any phase of NK function. These studies indicate that defective NK activity in SLE is secondary to an abnormality in the lytic event itself and is not due to a deficiency of NK cells, an abnormality in target binding, or an inability of NK cells to lyse mutiple targets. Additionally, serum factors do not appear to play a major etiologic role in the cytotoxic abnormalities of these patients.

Original languageEnglish
Pages (from-to)1966-1971
Number of pages6
JournalJournal of Immunology
Volume129
Issue number5
StatePublished - Dec 29 1982
Externally publishedYes

Fingerprint

Natural Killer Cells
Systemic Lupus Erythematosus
Chromium
K562 Cells
Serum
Lymphocytes

ASJC Scopus subject areas

  • Immunology

Cite this

Katz, P., Zaytoun, A. M., Lee, J. H., Panush, R. S., & Longley, S. (1982). Abnormal natural killer cell activity in systemic lupus erythematosus: An intrinsic defect in the lytic event. Journal of Immunology, 129(5), 1966-1971.

Abnormal natural killer cell activity in systemic lupus erythematosus : An intrinsic defect in the lytic event. / Katz, P.; Zaytoun, A. M.; Lee, J. H.; Panush, R. S.; Longley, S.

In: Journal of Immunology, Vol. 129, No. 5, 29.12.1982, p. 1966-1971.

Research output: Contribution to journalArticle

Katz, P, Zaytoun, AM, Lee, JH, Panush, RS & Longley, S 1982, 'Abnormal natural killer cell activity in systemic lupus erythematosus: An intrinsic defect in the lytic event', Journal of Immunology, vol. 129, no. 5, pp. 1966-1971.
Katz, P. ; Zaytoun, A. M. ; Lee, J. H. ; Panush, R. S. ; Longley, S. / Abnormal natural killer cell activity in systemic lupus erythematosus : An intrinsic defect in the lytic event. In: Journal of Immunology. 1982 ; Vol. 129, No. 5. pp. 1966-1971.
@article{bc88f310c4ea467f9be65ddea5cc9501,
title = "Abnormal natural killer cell activity in systemic lupus erythematosus: An intrinsic defect in the lytic event",
abstract = "The natural killer (NK) cell activity in fifteen systemic lupus erythematosus (SLE) patients was investigated by employing 51-chromium (51Cr) release microcytotoxicity and single cell cytotoxicity assays against K562 target cells. Although the SLE patients as a group had depressed NK function in the 51Cr-release assay compared to normal subjects (p < 0.005), those with clinically active disease displayed the greatest impairment in this activity (p < 0.001). Active SLE patients were deficient in overall NK activity (Vmax) (p < 0.005) but had normal percentages of potentially cytotoxic target binding cells (TBC). These TBC, however, were unable to normally kill bound target cells (p < 0.01), which is indicative of a deficiency of 'active' NK cells (p < 0.005). Those NK cells with intact cytotoxic capabilities could 'recycle' and repeat the lytic sequence normally. Exposure of normal lymphocytes to SLE sera did not impair any phase of NK function. These studies indicate that defective NK activity in SLE is secondary to an abnormality in the lytic event itself and is not due to a deficiency of NK cells, an abnormality in target binding, or an inability of NK cells to lyse mutiple targets. Additionally, serum factors do not appear to play a major etiologic role in the cytotoxic abnormalities of these patients.",
author = "P. Katz and Zaytoun, {A. M.} and Lee, {J. H.} and Panush, {R. S.} and S. Longley",
year = "1982",
month = "12",
day = "29",
language = "English",
volume = "129",
pages = "1966--1971",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

TY - JOUR

T1 - Abnormal natural killer cell activity in systemic lupus erythematosus

T2 - An intrinsic defect in the lytic event

AU - Katz, P.

AU - Zaytoun, A. M.

AU - Lee, J. H.

AU - Panush, R. S.

AU - Longley, S.

PY - 1982/12/29

Y1 - 1982/12/29

N2 - The natural killer (NK) cell activity in fifteen systemic lupus erythematosus (SLE) patients was investigated by employing 51-chromium (51Cr) release microcytotoxicity and single cell cytotoxicity assays against K562 target cells. Although the SLE patients as a group had depressed NK function in the 51Cr-release assay compared to normal subjects (p < 0.005), those with clinically active disease displayed the greatest impairment in this activity (p < 0.001). Active SLE patients were deficient in overall NK activity (Vmax) (p < 0.005) but had normal percentages of potentially cytotoxic target binding cells (TBC). These TBC, however, were unable to normally kill bound target cells (p < 0.01), which is indicative of a deficiency of 'active' NK cells (p < 0.005). Those NK cells with intact cytotoxic capabilities could 'recycle' and repeat the lytic sequence normally. Exposure of normal lymphocytes to SLE sera did not impair any phase of NK function. These studies indicate that defective NK activity in SLE is secondary to an abnormality in the lytic event itself and is not due to a deficiency of NK cells, an abnormality in target binding, or an inability of NK cells to lyse mutiple targets. Additionally, serum factors do not appear to play a major etiologic role in the cytotoxic abnormalities of these patients.

AB - The natural killer (NK) cell activity in fifteen systemic lupus erythematosus (SLE) patients was investigated by employing 51-chromium (51Cr) release microcytotoxicity and single cell cytotoxicity assays against K562 target cells. Although the SLE patients as a group had depressed NK function in the 51Cr-release assay compared to normal subjects (p < 0.005), those with clinically active disease displayed the greatest impairment in this activity (p < 0.001). Active SLE patients were deficient in overall NK activity (Vmax) (p < 0.005) but had normal percentages of potentially cytotoxic target binding cells (TBC). These TBC, however, were unable to normally kill bound target cells (p < 0.01), which is indicative of a deficiency of 'active' NK cells (p < 0.005). Those NK cells with intact cytotoxic capabilities could 'recycle' and repeat the lytic sequence normally. Exposure of normal lymphocytes to SLE sera did not impair any phase of NK function. These studies indicate that defective NK activity in SLE is secondary to an abnormality in the lytic event itself and is not due to a deficiency of NK cells, an abnormality in target binding, or an inability of NK cells to lyse mutiple targets. Additionally, serum factors do not appear to play a major etiologic role in the cytotoxic abnormalities of these patients.

UR - http://www.scopus.com/inward/record.url?scp=0019904543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019904543&partnerID=8YFLogxK

M3 - Article

VL - 129

SP - 1966

EP - 1971

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -